-+ 0.00%
-+ 0.00%
-+ 0.00%

Izertis (BME:IZER) Stock Price Trails Revenue Growth As Margins Thin

Simply Wall St·10/02/2026 02:23:40
Listen to the news

Izertis entered this earnings release with a stretched story. The stock has slipped roughly 12% over three months while still carrying a very high trailing P/E of 132.9x, a mix that already signalled fragile confidence.

The report did not ease that tension. Revenue for H1 2026 reached €98.095m, yet net income sat at only €0.559m, leaving the trailing net margin at 1.1% compared with 3.7% a year earlier. That margin squeeze is what the market is trading, even as longer term growth assumptions and a higher DCF estimate pull sentiment in the opposite direction.

Like the long term growth story at Izertis but uneasy about paying a 132.9x P/E for a business running on a 1.1% net margin? Take a look at our 224 resilient stocks with low risk scores for ideas with stronger profitability and lower risk profiles.

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): €98.095m vs. €76.47m (up about 28.2%)
  • Net Income (Excl. Extra Items, H1 2026 vs. H1 2025): €0.559m vs. €2.475m (down about 77.4%)
  • Basic EPS (H1 2026 vs. H1 2025): €0.02 vs. €0.089038 (down about 77.5%)
  • Trailing Net Profit Margin (Last 12 Months vs. Prior Year): 1.1% vs. 3.7% (indicating a compressed margin profile despite a higher revenue base)

Tired of squinting at dense earnings tables and tiny margin figures? Get a clear visual view of Izertis with a full chart-based breakdown of its valuation in our company report for izertis.

BME:IZER Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
BME:IZER Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Izertis growth story meets thinner profitability

Izertis still tells a growth story. Revenue in H1 2026 reached €98.095m against €76.47m a year earlier, which fits a narrative of a digital consultancy winning more work across its client base. The share price is lower over 3 and 12 months, yet the top line points to customers continuing to spend with the group. For a bullish view, the key comfort is simple: clients are not walking away, and the broader digital transformation pitch still appears to translate into higher sales.

Profit squeeze keeps the Izertis risk debate alive

Profitability is where the risk case bites. Net income excluding extra items dropped from €2.475m in H1 2025 to €0.559m in H1 2026, with the trailing net margin now at 1.1% versus 3.7%. That compression undercuts the idea of a scalable, high return consultancy and makes the recent share price decline of roughly 12% over 90 days look directionally aligned with earnings pressure. The business is growing, but the current set of numbers reinforces concerns about how much of that activity actually converts into shareholder value.

Compare Izertis’ internal growth story with what the street is pricing in at €7.5. See the consensus price target analysis for izertis to check whether analysts think this premium P/E and thin margin profile can hold.

Stay Ahead Of Your Next Move

If the mix of high P/E and thin margins at Izertis has your attention, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and wait for a setup that fits your plan. When you do decide to act, manage every position in one place with the Portfolio Command Center so you only see the updates that genuinely matter. For a longer term view, tap into crowd insights through the Community and see how other investors are thinking about risks and potential catalysts. That way you can spot key turning points early and stay a step ahead of the market.

Seeking Alternatives Beyond Izertis?

Fresh ideas move first. Once momentum hits, prices can be flying before the crowd even notices. Scan these under the radar for now opportunities and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.